
Jae W. Lee
Examiner (ID: 12916, Phone: (571)272-9949 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656 |
| Total Applications | 1156 |
| Issued Applications | 824 |
| Pending Applications | 90 |
| Abandoned Applications | 268 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17649904
[patent_doc_number] => 11352618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Modified organisms for improved flavor and aroma
[patent_app_type] => utility
[patent_app_number] => 16/383086
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2174
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383086 | Modified organisms for improved flavor and aroma | Apr 11, 2019 | Issued |
Array
(
[id] => 14994289
[patent_doc_number] => 20190316102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => MODIFICATION OF IMMUNE-RELATED GENOMIC LOCI USING PAIRED CRISPR NICKASE RIBONUCLEOPROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/383135
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383135
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/383135 | MODIFICATION OF IMMUNE-RELATED GENOMIC LOCI USING PAIRED CRISPR NICKASE RIBONUCLEOPROTEINS | Apr 11, 2019 | Abandoned |
Array
(
[id] => 16361339
[patent_doc_number] => 20200318090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Thermophile Peptidoglycan Hydrolase Fusion Proteins and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/375287
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375287 | Thermophile peptidoglycan hydrolase fusion proteins and uses thereof | Apr 3, 2019 | Issued |
Array
(
[id] => 14930443
[patent_doc_number] => 20190300859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METHOD TO ALTER CHINESE HAMSTER OVARY CELL LINE STABILITY
[patent_app_type] => utility
[patent_app_number] => 16/372932
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372932 | Method to alter Chinese hamster ovary cell line stability | Apr 1, 2019 | Issued |
Array
(
[id] => 18085718
[patent_doc_number] => 11535837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Mannanase variants and polynucleotides encoding same
[patent_app_type] => utility
[patent_app_number] => 17/041522
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38837
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041522
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041522 | Mannanase variants and polynucleotides encoding same | Mar 26, 2019 | Issued |
Array
(
[id] => 17875766
[patent_doc_number] => 11447769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Modified immune cells having enhanced function and methods for screening for same
[patent_app_type] => utility
[patent_app_number] => 16/365326
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 63
[patent_no_of_words] => 59178
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365326
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/365326 | Modified immune cells having enhanced function and methods for screening for same | Mar 25, 2019 | Issued |
Array
(
[id] => 15148243
[patent_doc_number] => 20190352599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => MEDIUM CONTAINING URIDINE AND N-ACETYL-D-MANNOSAMINE
[patent_app_type] => utility
[patent_app_number] => 16/364304
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16364304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/364304 | Medium containing uridine and N-acetyl-D-mannosamine | Mar 25, 2019 | Issued |
Array
(
[id] => 17620346
[patent_doc_number] => 11339385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Modified nucleic acid editing systems for tethering donor DNA
[patent_app_type] => utility
[patent_app_number] => 16/363642
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 20
[patent_no_of_words] => 11315
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363642
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363642 | Modified nucleic acid editing systems for tethering donor DNA | Mar 24, 2019 | Issued |
Array
(
[id] => 15163673
[patent_doc_number] => 10487318
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-11-26
[patent_title] => Compositions and methods for treating celiac sprue disease
[patent_app_type] => utility
[patent_app_number] => 16/360190
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12415
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360190
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360190 | Compositions and methods for treating celiac sprue disease | Mar 20, 2019 | Issued |
Array
(
[id] => 14897605
[patent_doc_number] => 20190292568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => GENOMIC EDITING IN AUTOMATED SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/358461
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358461 | GENOMIC EDITING IN AUTOMATED SYSTEMS | Mar 18, 2019 | Abandoned |
Array
(
[id] => 14502149
[patent_doc_number] => 20190194729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/299068
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299068
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/299068 | RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF | Mar 10, 2019 | Abandoned |
Array
(
[id] => 14743901
[patent_doc_number] => 20190255124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/293789
[patent_app_country] => US
[patent_app_date] => 2019-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16293789
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/293789 | Compositions and methods for improving mitochondrial function | Mar 5, 2019 | Issued |
Array
(
[id] => 14439751
[patent_doc_number] => 20190177748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => FERMENTATIVE PRODUCTION OF ETHANOL FROM GLUCOSE, GALACTOSE AND ARABINOSE EMPLOYING A RECOMBINANT YEAST STRAIN
[patent_app_type] => utility
[patent_app_number] => 16/283208
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283208 | Fermentative production of ethanol from glucose, galactose and arabinose employing a recombinant yeast strain | Feb 21, 2019 | Issued |
Array
(
[id] => 15210419
[patent_doc_number] => 20190367896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => PHOSPHOKETOLASES FOR IMPROVED PRODUCTION OF ACETYL COENZYME A-DERIVED METABOLITES, ISOPRENE, ISOPRENOID PRECURSORS, AND ISOPRENOIDS
[patent_app_type] => utility
[patent_app_number] => 16/276558
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16276558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/276558 | Phosphoketolases for improved production of acetyl coenzyme A-derived metabolites, isoprene, isoprenoid precursors, and isoprenoids | Feb 13, 2019 | Issued |
Array
(
[id] => 15345843
[patent_doc_number] => 20200010813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => ACYL-ACP REDUCTASE WITH IMPROVED PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/272303
[patent_app_country] => US
[patent_app_date] => 2019-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/272303 | Acyl-ACP reductase with improved properties | Feb 10, 2019 | Issued |
Array
(
[id] => 15148309
[patent_doc_number] => 20190352632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => ENGINEERED TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR (TALE) DOMAINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/266937
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16266937
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/266937 | Engineered transcription activator-like effector (TALE) domains and uses thereof | Feb 3, 2019 | Issued |
Array
(
[id] => 16627561
[patent_doc_number] => 20210046214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => THERAPEUTIC AGENT FOR INTERVERTEBRAL DISC DEGENERATION AND MATERIAL FOR CULTURING INTERVERTEBRAL DISC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/966226
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966226
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966226 | Therapeutic agent for intervertebral disc degeneration and material for culturing inter vertebral disc cells | Jan 30, 2019 | Issued |
Array
(
[id] => 16215368
[patent_doc_number] => 10731168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-04
[patent_title] => Protease deficient filamentous fungal cells and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/251194
[patent_app_country] => US
[patent_app_date] => 2019-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 91
[patent_no_of_words] => 67518
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16251194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/251194 | Protease deficient filamentous fungal cells and methods of use thereof | Jan 17, 2019 | Issued |
Array
(
[id] => 17453246
[patent_doc_number] => 11268092
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Structure-engineered guide RNA
[patent_app_type] => utility
[patent_app_number] => 16/247311
[patent_app_country] => US
[patent_app_date] => 2019-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15602
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16247311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/247311 | Structure-engineered guide RNA | Jan 13, 2019 | Issued |
Array
(
[id] => 14277301
[patent_doc_number] => 20190135935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/240592
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16240592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/240592 | Prevention of disulfide bond reduction during recombinant production of polypeptides | Jan 3, 2019 | Issued |